10 Aug SCALING NEW HEIGHTS IN CELL AND GENE THERAPY WORKSHOP

Aviara B

In order to overcome the challenges currently facing cell and gene therapies (C&GT), the next generation of manufacturers must prepare to serve small and large patient populations across a wide range of care settings to harmonize clinical workflows, reduce HCP burden and deliver therapies at a fraction of the current cost. This cannot be achieved by incrementally tweaking the existing model. Rather, it requires leapfrogging the current C&GT 1.0 “proof-of-concept” to deliver fundamentally new capabilities. To deliver on the promise of C&GT 2.0, a new approach is required, one that considers the needs more holistically across the end-to-end patient journey.

Moderator:

Bill Coyle, Principal, Global Head of BioPharma Vertical, ZS

Speaker:

Jonathon DiTroia, Vice President, Strategy, Cell, Gene and Advanced Therapies, McKesson

Event Timeslots (1)

Tuesday | October 10, 2023
7:45 am - 8:45 am
brady